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RARE SYNDROMES: WHAT THEY TEACH US ABOUT OSTEOARTHRITIS
DISEASE MECHANISMS
J.A. Gallagher. Univ. of Liverpool, Liverpool, United Kingdom
William Harvey, the great English physician of the 17th century
observed “Nature is nowhere accustomed more openly to display her
secret mysteries than in cases where she shows tracings of her work-
ings apart from the beaten paths; nor is there any better way to
advance the proper practice of medicine than to give our minds to the
discovery of the usual law of nature, by careful investigation of cases of
rarer forms of disease”. Harvey’s words have indeed been prophetic;
the biomedical literature contains numerous examples of how research
on the extreme phenotypes of monogenic diseases has helped eluci-
date the molecular pathogenesis of more common disorders. Several
therapies for common diseases, including the blockbuster drugs statins
and bisphosphonates, were discovered in part through the study of rare
syndromes.
Despite the examples from other ﬁelds on the wider beneﬁts of rare
disease research, the potential impact of studying less common carti-
lage syndromes on osteoarthritis (OA) has been relatively neglected.
However, recent investigations from several laboratories have high-
lighted the more general lessons that can be learnt from research on
diseases such as chondrodysplasias, familial chondrocalcinosis, Kashin-
Beck Disease (KBD) and the osteoarthropathy of alkaptonuria (AKU).
Research on the rare mutations responsible for chondrodysplasias has
identiﬁed genes such as GDF5, which plays a key role in skeletal
development. Polymorphisms in this same gene provide one of the best
characterised genetic associations with OA susceptibility. Mutation of
the ANKH gene in chondrocalcinosis has highlighted the role that this
gene plays in the physiological and pathological mineralisation of car-
tilage. The expression of ANKH, which codes for a pyrophosphate
transporter is known to be dysregulated in OA. Research on KBD has
identiﬁed aberrations in gene expression and cell signalling some of
which are also observed in OA.
AKU is a single gene defect in tyrosine metabolism that leads to an early
onset, aggressive joint degeneration. Although joint destruction in AKU
is associated with the deposition of pigmented polymers in cartilage,
termed ochronosis, there are several parallels with the pathophysiology
of OA. Studies on tissue samples from patients with AKU, and from a
mouse model of the disease, have revealed previously unrecognised
microanatomical, cellular and biochemical changes in joints which have
been subsequently also detected in human OA. These include early
changes in the integrity of collagen ﬁbrils, the role of calciﬁed cartilage
in the initiation of OA, thinning and cracking of the subchondral plate
and aberrant non-Frostian bone remodelling with the formation of
novel microanatomical structures described as trabecular excrescences.
All of these features are abundant and easily recognisable in the severe
phenotype of AKU but require more careful observation in OA because
they occur at a lower frequency.
In conclusion, there is overwhelming evidence that studying rare car-
tilage syndromes with extreme phenotypes can help elucidate the
pathophysiological mechanisms involved in the initiation and pro-
gression of joint destruction. Further support for rare disease research1063-4584/$ – see front matter“apart from the beaten paths” could make a signiﬁcant contribution to
the development of effective therapies for OA and the identiﬁcation of
new biomarkers.
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MICRO-RNA AND CHONDROCYTE FUNCTION
M. Sato. Tokai Univ. Sch. of Med., Isehara, Japan
MicroRNAs (miRNAs) are single-stranded noncoding RNAs ofw22 base
pairs that regulate gene expression by repressing translation. In 1993,
the ﬁrst miRNA, lin-4, was discovered in nematodes, and subsequent
studies have shown that miRNAs regulate w30% of all human genes.
miRNA is transcribed initially from miRNA genes into a long primary
transcript (pri-miRNA), which is then cleaved by Drosha to produce
precursor miRNA (pre-miRNA). The pre-miRNA is then transported to
the cytoplasm using exportin-5, and there it is cleaved by Dicer to yield
miRNA. The miRNA then combines with an argonaute protein to form
RISC, which sequence-speciﬁcally recognizes and represses the trans-
lation of target RNAs. Abnormalities in cartilage development have been
observed in Dicer gene dysfunction models, and miRNA is known to
play a key role in cartilage differentiation. miRNA plays a key role in
differentiation and growth in organs and tissues, andmiRNAs expressed
speciﬁcally in cartilage have been reported. To date, miR-21, miR-22,
miR-27a, miR-140, miR-146, and so on have been reported as miRNAs
that are associated with cartilage metabolism. Many studies have
reported the use of a microarray analysis for isolating miRNAs that are
expressed in a tissue-speciﬁc manner. For example, Miyaki et al. per-
formed microarray analysis of mesenchymal stem cells and articular
chondrocytes, and they observed a high expression of miR-140 in
chondrocytes. They also observed that the expression of miR-140
increased during chondrogenesis. In addition, they reported that miR-
140 expression was lower in the osteoarthritis (OA) group than in the
normal group. Iliopoulos et al. performed microarray analysis using
normal chondrocytes and chondrocytes isolated from OA. They repor-
ted an increased expression of miR-22 and a decreased expression of
miR-140 in the OA group. They also reported that the expressions of IL-
1beta and MMP13 were increased, whereas the expression of aggrecan
was decreased in the group that showed increased miR-22 expression.
On the other hand, using microarray analysis, we focused on three types
of miRNAs, i.e., miR-199a-3p, miR-193b, and miR-320c, and their
expressions were observed to vary with age. We harvested cartilage
tissue from patients with polydactylism, anterior cruciate ligament
injury, and OA undergoing total knee arthroplasty, and we used
microarrays to identify miRNAs whose expression is upregulated or
downregulated with age. The results were assessed by real-time PCR
and MTT assay in a mimic group, in which synthetic double-stranded
RNA from the isolated miRNAwas transfected to upregulate expression,
and in an inhibitor group, inwhich the miRNAwas bound speciﬁcally to
downregulate expression. The expression of two miRNAs (miR-199a-3p
and miR-193b) was upregulated with age, and that of one miRNA (miR-
320c) was downregulated with age. A real-time PCR assay showed that
type 2 collagen, aggrecan, and SOX9 expression were downregulated in
the miR-199a-3p mimic group but were upregulated in the inhibitor
